• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multi-cohort gene expression model enhances prognostic stratification in diffuse large B-cell lymphoma.

作者信息

Filho Valbert Oliveira Costa, Mesquita Felipe Pantoja, Saldanha Erick Figueiredo, Passos Pedro Robson Costa, Noronha Mariana Macambira, Rabenhorst Silvia Helena Barem

机构信息

Center of Research and Drug Development (NPDM), Federal University of Ceara, Fortaleza, Brazil.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health, Biomedical Research Center, Federal University of Ceara, Fortaleza, Brazil.

出版信息

Hematol Transfus Cell Ther. 2025 Jun 12;47(3):103847. doi: 10.1016/j.htct.2025.103847.

DOI:10.1016/j.htct.2025.103847
PMID:40513296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12205312/
Abstract
摘要

相似文献

1
Multi-cohort gene expression model enhances prognostic stratification in diffuse large B-cell lymphoma.多队列基因表达模型增强弥漫性大B细胞淋巴瘤的预后分层
Hematol Transfus Cell Ther. 2025 Jun 12;47(3):103847. doi: 10.1016/j.htct.2025.103847.
2
Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim F-FDG PET-CT Analysis and the NCCN-IPI: A Multicenter Retrospective Study.通过整合中期F-FDG PET-CT分析和NCCN-IPI对弥漫性大B细胞淋巴瘤进行风险分层：一项多中心回顾性研究
Hematol Oncol. 2025 Jul;43(4):e70118. doi: 10.1002/hon.70118.
3
Genetic Subtype-Based International Prognostic Index Prognostic Model in Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤中基于基因亚型的国际预后指数预后模型
MedComm (2020). 2025 Jun 16;6(7):e70190. doi: 10.1002/mco2.70190. eCollection 2025 Jul.
4
A novel cancer-associated fibroblast-related gene signature for predicting diffuse large B cell lymphoma prognosis using weighted gene co-expression network analysis and machine learning.一种利用加权基因共表达网络分析和机器学习预测弥漫性大B细胞淋巴瘤预后的新型癌症相关成纤维细胞相关基因特征。
J Int Med Res. 2025 Apr;53(4):3000605251331250. doi: 10.1177/03000605251331250. Epub 2025 Apr 25.
5
Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.弥漫性大 B 细胞淋巴瘤预后预测模型的建立与验证。
Front Endocrinol (Lausanne). 2022 Apr 14;13:846357. doi: 10.3389/fendo.2022.846357. eCollection 2022.
6
A three-gene signature based on , and improves risk stratification in diffuse large B-cell lymphoma.基于、和的三基因签名可改善弥漫性大 B 细胞淋巴瘤的风险分层。
Haematologica. 2021 Sep 1;106(9):2405-2416. doi: 10.3324/haematol.2019.236455.
7
A Novel Prognostic Score for Disease Progression and Mortality in Patients With Newly Diagnosed Primary Large B-Cell Lymphoma of Immune-Privileged Sites.一种用于新诊断的免疫豁免部位原发性大B细胞淋巴瘤患者疾病进展和死亡率的新型预后评分
Hematol Oncol. 2025 Jul;43(4):e70115. doi: 10.1002/hon.70115.
8
Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中5-甲基胞嘧啶相关基因的鉴定与验证
Heliyon. 2023 Nov 10;9(11):e22209. doi: 10.1016/j.heliyon.2023.e22209. eCollection 2023 Nov.
9
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma.原发性睾丸弥漫性大B细胞淋巴瘤的预后基因表达、微小RNA谱特征及基因改变
Blood Cancer J. 2025 Jul 17;15(1):123. doi: 10.1038/s41408-025-01323-8.
10
A Novel CD58 Mutation-Related Signature Predicts Prognosis Risk in Diffuse Large B-Cell Lymphoma Patients.一种新型CD58突变相关特征预测弥漫性大B细胞淋巴瘤患者的预后风险。
Cancer Res Treat. 2025 Jul 28. doi: 10.4143/crt.2024.1143.

本文引用的文献

1
Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma.整合基因亚型与PET扫描监测以预测弥漫性大B细胞淋巴瘤的预后。
Nat Commun. 2025 Jan 2;16(1):109. doi: 10.1038/s41467-024-55614-y.
2
Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials.识别 upfront chemoimmunotherapy 治疗预后不良的 DLBCL 患者的挑战及其对一线临床试验的影响。
Leuk Lymphoma. 2024 Apr;65(4):430-439. doi: 10.1080/10428194.2023.2298705. Epub 2024 Jan 5.
3
Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models.
弥漫性大 B 细胞淋巴瘤的预后指标：多种模型的基于人群的比较和验证研究。
Blood Cancer J. 2023 Oct 13;13(1):157. doi: 10.1038/s41408-023-00930-7.
4
Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma.基线 PET 放射组学预测弥漫性大 B 细胞淋巴瘤结局优于 IPI 风险评分。
Blood. 2023 Jun 22;141(25):3055-3064. doi: 10.1182/blood.2022018558.
5
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.通过对多个同步活检样本进行大规模平行测序分析大切除弥漫性大B细胞淋巴瘤肿块中的空间异质性
Cancers (Basel). 2021 Feb 6;13(4):650. doi: 10.3390/cancers13040650.
6
Genetic and epigenetic determinants of diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤的遗传和表观遗传决定因素。
Blood Cancer J. 2020 Dec 4;10(12):123. doi: 10.1038/s41408-020-00389-w.
7
Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review.用于弥漫性大 B 细胞淋巴瘤患者风险分层的现有预后模型：系统评价。
Crit Rev Oncol Hematol. 2019 Jan;133:1-16. doi: 10.1016/j.critrevonc.2018.10.006. Epub 2018 Nov 1.
8
Diffuse large B-cell lymphoma: R-CHOP failure-what to do?弥漫性大B细胞淋巴瘤：R-CHOP方案治疗失败后该怎么办？
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):366-378. doi: 10.1182/asheducation-2016.1.366.
9
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.弥漫性大B细胞淋巴瘤（DLBCL）：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v116-25. doi: 10.1093/annonc/mdv304.